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During the last few years a quiet revolution has been taking place in our ideas about the genetical basis of inherited disease. One way in which this has been manifested is by the increasing use in the literature of the term 'genetic heterogeneity', a term which is usually meant to imply that the same or very similar clinical syndromes may be produced by a number of quite different gene mutations. That this could indeed occur has of course been recognized for a long time (Harris, 1956) . But whereas in the past it was considered by most workers, at least implicitly, to be an unusual and somewhat infrequent phenomenon, it is now becoming increasingly apparent that it is a common and widespread feature of many inherited disorders (Harris, 1970; McKusick, 1973) . In other words it now seems that 'genetic heterogeneity' will prove to be the rule rather than the exception. But it has also become clear that such heterogeneity can arise in several different ways. And in the present paper I would like to consider the basic types of cause which may give rise to the phenomenon, and attempt to arrive at a classification which might be useful in practice.
Multiple Allelism
It is convenient to start from a somewhat theoretical point of view by considering the question of multiple allelism, that is to say, the alternative forms or alleles of a particular gene which may occur among different individuals in a given population.
In theory, a very large number of structurally different alleles may be generated by separate mutational events within the confines of a single gene. For example, from a typical gene containing a DNA sequence of say 900 bases and coding for a protein of 300 amino acids, as many as 2700 different alleles may be generated simply from mutational events which result in no more than a single base change at some point in the sequence. This is so because each base may be changed to one of three others. In addition it is also known that other types of mutational event resulting in small deletions, duplications, frame shifts, etc, may also (Stamatoyannopoulos, 1972) . These different haemolytic states, although they vary somewhat in degree, appear for the most part to be difficult to distinguish from each other on clinical or pathological grounds alone. And before their characterization by structural studies on the haemoglobin present, they would no doubt have been regarded as a single genetic entity with perhaps some superimposed variability, or at most two or three separate syndromes each determined by a single mutation. Thus this represents a very striking example of genetic heterogeneity.
There is no reason to think that the haemoglobin fl-gene locus is in any way peculiar in this respect . More than 80 different variants of the enzyme glucose-6-phosphate dehydrogenase (Yoshida, Beutler, and Motulsky, 1971; Beutler and Yoshida, 1973) (Yoshida, 1973 (Lesch and Nyhan, 1964; Seegmiller, Rosenbloom, and Kelley, 1967; Kelley and Meade, 1971) , while others result in less severe enzyme defects which are expressed clinically as gout in adolescence or early adult life (Kelley, 1968) . Numerous examples of multiple allelic variants of other proteins, such as albumin, transferrin, and serum il-antitrypsin, have been reported, and surveys on a wide variety of different enzymes carried out in our own laboratory have revealed a widespread occurrence of variants strictly analogous to those identified in the cases of haemoglobin and glucose-6-phosphate dehydrogenase (Harris, Hopkinson, and Robson, 1974) . Indeed it now appears probable that, at virtually all gene loci coding for enzyme and protein structure, a large number of the different possible mutant alleles which may be generated by separate mutations actually exist among living members of the species.
An interesting point emerges from all this. In the past it was usually assumed that if a particular disorder segregated in families in the manner of a typical autosomal recessive characteristic, then the affected individuals were ipso facto homozygous for a single mutant gene. It is, however, now apparent from the degree of multiple allelism which evidently occurs that this conclusion will often be mistaken. Although a condition segregates as an autosomal recessive, it will in many cases be due to heterozygosity fortwo different mutant alleles each producing a functional abnormality in the particular enzyme or protein but in a different way. Such heterozygous individuals would have received one of the abnormal alleles from one parent and one from the other, eachof whom would usually also be carrying the normal allele. So typical segregation patterns with quarter ratios would be obtained. A well known example is sickle-cell-haemoglobin C disease. But other examples involving enzyme defects in inborn errors of metabolism are now beginning to be reported, for instance in such conditions as pyruvate kinase deficiency (Paglia, Valentine, and Rucknagel, 1972) and phosphohexose isomerase deficiency (Detter, Ways, Giblett, Baughan, Hopkinson, Povey, and Harris, 1972) .
Compound heterozygosity of this sort is probably by no means uncommon in recessively inherited diseases due to enzyme defects. But it may often be peculiarly difficult to recognize in conditions determined by genes on autosomal chromosomes because it involves in the patients the characterization of the products of two different alleles in a mixture where the total enzyme activity is by the very nature of the situation markedly reduced.
Before leaving the question of multiple allelism it is perhaps worth pointing out that while this is an important cause A rather obvious example is provided by the complex network of metabolic reactions which is present in the red cell, and is necessary for maintaining its functional and structural integrity. Disruption of the normal metabolism of the red cell, with its consequent premature destruction and hence chronic haemolytic disease, can clearly occur as a result of defects in a number of quite different enzymes. And indeed, a series of clinically not very dissimilar forms of genetically determined haemolytic anaemias have already been differentiated and shown to be due to deficiencies of quite different enzymes determined by separate gene loci. These various haemolytic diseases vary considerably in severity. But in practice it seems that they are difficult to differentiate one from another in the absence of information provided by enzyme studies. This difficulty is further enhanced by the fact that at any one of these loci, multiple alleles, which differ in the degree of enzyme deficit they produce and hence in the clinical severity, may also occur. So superimposed on the variation due to mutations at separate loci affecting different enzymes is the added variation due to multiple allelism at a single locus.
Storage diseases, such as the sphingolipidoses, the mucopolysaccharidoses, and the glycogen storage diseases, provide further examples of the same general phenomenon. The normal degradation of each of these classes of complex macromolecules is effected by the sequential action of a series of different enzymes, and a specific deficiency of one or another enzyme in the sequence results in progressive accumulation of the partially degraded macromolecules. It is not surprising, therefore, that very similar consequences may often result from mutations affecting quite different enzymes involved with the degradation of the same macromolecule. For example, in the case of the mucopolysaccharidoses, the syndromes now known as Sanfilippo A and B are apparently indistinguishable clinically (McKusick, 1972 ). Yet they are due to mutations at separate loci determining different enzymes, namely, heparan sulphate sulphatase in Sanfilippo A (Kresse and Neufeld, 1972) and N-acetyl-cx-glucosaminidase in Sanfilippo B (O'Brien, 1972; Figura and Kresse, 1972 (Matalon and Dorfman, 1972; Bach, Friedman, Weissmann, and Neufeld, 1972) , while in Hunter's disease it is sulphoiduronate sulphatase (Bach, Eisenberg, Cantz, and Neufeld, 1973) . Both enzymes are normally concerned in degrading the mucopolysaccharides which accumulate, and it is not surprising therefore that the two syndromes resemble each other so closely.
Other Causes of Heterogeneity
It is important to remember that variation in the expression of a particular inherited disease in different individuals may derive not only from differences in the particular mutant genes causing the specific enzyme or protein defect which is the basic cause of the disease in question, but also from differences in the rest of the genetical constitution of the individuals in which the particular abnormal gene occurs. There is now an extensive body of data which indicates that probably no two individuals, with the exception of monozygotic twins, are exactly alike in their enzyme and protein constitutions, because of the common allelic differences (so-called polymorphisms) which occur at very many gene loci (Harris, 1970; Harris and Hopkinson, 1972) . Such so-called 'normal variations' in genetic background, because they must define many of the details of the biochemical milieu against which the effects of particular abnormal genes are expressed, may well result in differences in the manifestations of a particular disorder in different affected patients. Some (Eriksson, 1964 (Eriksson, , 1965 
